Posted on December 27, 2018 by Sitemaster
A new paper in the Journal of Clinical Oncology has just reported that the overall survival (OS) of black and white men diagnosed with metastatic castration-resistant prostate cancer (mCRPC) seems to be near to identical after treatment with docetaxel or a docetaxel-containing regimen. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: black, castration-resistant, docetaxel, mCRPC, metastatic, race, survival, white | Leave a comment »
Posted on December 19, 2018 by Sitemaster
Posted on October 15, 2018 by Sitemaster
A newly published paper has now suggested that data from a single PSA test carried out when the men are between 40 and 64 years of age can be used to project risk for aggressive prostate cancer among African-American men. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: African=American, black, PSA, risk, testing | 2 Comments »
Posted on July 30, 2015 by Sitemaster
A newly published article in the British Medical Journal has shown that black males in England are twice as likely to be diagnosed with prostate cancer as white males, and are twice as likely to die of prostate cancer too. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: asian, black, England, ethnicity, incidence, mortality, race, white | 1 Comment »
Posted on December 24, 2014 by Sitemaster
The issue of treatment regret comes up regularly among men after first-line treatment for localized prostate cancer, but has been less commonly addressed among men with recurrent disease post-treatment. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: black, race, regret, Treatment | 1 Comment »
Posted on February 11, 2013 by Sitemaster
We have known for some time that regular exercise may lower risk for prostate cancer. Indeed, a study by Clarke and Whittemore published in 2000 suggested that men who take little to no exercise may be 1.7 times more likely to be diagnosed with prostate cancer than those who exercise with a degree of regularity. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: black, Diagnosis, exercise, race, risk, white | 6 Comments »
Posted on August 24, 2012 by Sitemaster
In a number of papers dating back to the 1990s, Moul and colleagues clearly demonstrated that simply being African American places men with prostate cancer at greater risk for biochemical progression after surgical treatment than men of white race — even in an equal access health care system like that of the US military. … READ MORE …
Filed under: Management, Treatment | Tagged: African American, black, outcome, risk, surgery | 1 Comment »
Posted on October 4, 2011 by Sitemaster
A review article on issues affecting perceptions of prostate cancer among Black men of African, Afro-Caribbean, and African American ethnicity has highlit the very limited data available about prostate cancer, its diagnosis, and its management in males from specific ethnic groups inside and outside the USA. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Australia, black, ethnicity, indigenous, native American | Leave a comment »
Posted on May 23, 2011 by Sitemaster
A newly published article, available on-line in the journal Prostate Cancer and Prostatic Diseases, shows that tissues from prostate biopsies from black men express higher levels of biomarkers for aggressive disease than do tissues from prostate biopsies taken from white men. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aggressive, biomarker, black, risk, white | Leave a comment »